If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Zepbound ® (tirzepatide) injection
2.5 mg/ 5 mg/ 7.5 mg/ 10 mg/ 12.5 mg/ 15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can people taking Zepbound™ (tirzepatide) receive a COVID-19 vaccine?
The use of the COVID-19 vaccine in patients treated with tirzepatide has not been studied.
See important safety information, including boxed warning, in the attached prescribing information.
Use of COVID-19 Vaccines in Patients Receiving Tirzepatide
While some participants may have received a coronavirus disease (COVID-19) vaccine during their participation in tirzepatide studies, the safety and efficacy of tirzepatide used in patients who have received a coronavirus disease (COVID-19) vaccine have not been studied by Eli Lilly and Company. Please talk to your health care provider about whether you should get a COVID-19 vaccine.
For additional questions regarding your treatment with tirzepatide and a COVID-19 vaccine, contact your health care provider. For current information and updates on a potential COVID-19 vaccine, please visit: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html.
Enclosed Prescribing Information
Date of Last Review: November 08, 2023